# Rule 5 — R5-M6B Medicine Evidence Audit: GE (Green Electricity)

## 1. Document control

| Field | Value |
|-------|--------|
| **Owner** | Dr. Ghanshyam Bakalwar |
| **Phase** | R5-M6B |
| **Audit sequence** | 18 of 38 |
| **Medicine code** | GE |
| **Classification** | DOCUMENTATION_ONLY_MEDICINE_AUDIT (canonical **Electricity** category — not conventional oral materia) |
| **Audit record version** | 1.0 |
| **Audit date** | 2026-08-09 |
| **Repository base (EHAS2)** | `7ff19249044c885773c489558c527a51a1d1fe4f` |
| **Framework** | [rule-05-medicine-evidence-audit-framework-R5-M6B.md](./rule-05-medicine-evidence-audit-framework-R5-M6B.md) |
| **Index** | [rule-05-medicine-evidence-audit-index-R5-M6B.md](./rule-05-medicine-evidence-audit-index-R5-M6B.md) |
| **Audit sequence authority** | Index §2 / §3 canonical order (not registry JSON array order where it differs) |
| **Verdict code** | `GE_DOCUMENTATION_AUDIT_COMPLETE_CLINICAL_AND_SAFETY_BLOCKED` |
| **Owner-primary posture** | **`PROVISIONAL_OWNER_PRIMARY`** (occurrence **A** only — owner-session **Green Electricity** master block indexed as **`MED=None`**) |

**Mandatory normalizer posture:** **No normalized `MED=GE` owner header exists** in the 019c normalized corpus. Owner-session Green Electricity master text is indexed only as **`MED=None` L1467** (jsonl **1780**). This record accepts that block as a **provisional owner-primary electricity-master** occurrence only. **This classification does not authorize GE application, route, electricity exposure, or co-administration.**

---

## 2. Repository / base / registry identity

| Item | Value |
|------|--------|
| **Canonical repository** | `bakalwar/EH_AROGYA_SUTRA_2` |
| **Registry version** | `ehas2-medicine-registry-v2` |
| **Medicine count** | 38 |
| **C11** | Excluded from v2 38-set (`registry.v2.manifest.json` → `excludedCodes: ["C11"]`); **not** remapped or replaced |
| **Canonical sequence** | **F2 → GE → L1** |
| **Registry identity (GE code in 38-set)** | **VERIFIED** — code `GE` present in v2 registry; **not** owner-source verification |
| **Registry group category** | **`Electricity`** (`group_type` in `medicines.v2.json`) — **not** a conventional oral medicine block |
| **Normalized `MED=GE` header** | **ABSENT** — negative search across normalized owner corpus (**OPEN** — CF-GE-001) |
| **Owner electricity master anchor** | **`MED=None` L1467** · jsonl **1780** · declared len **2916** |
| **Owner-primary verification** | **PARTIAL** — **`PROVISIONAL_OWNER_PRIMARY`** (occurrence **A** only); **`ownerPrimaryVerified: false`** |
| **Provenance (index vocabulary)** | **`INCOMPLETE_NOT_VERIFIED`** |
| **Transcript byte proof** | **PENDING** — jsonl line **1780** not byte-verified in available read-only trees |
| **Declared transcript length** | **2916** — **OPEN** vs MM3 `doctor_chars: 2912` (4-char delta unresolved) |
| **GE inner wrapper (occurrence A)** | `<user_query>` opens **L1470** and **closes at L1507** |
| **Physical predecessor** | **YE** electricity master (wrapper closes **L1464**) |
| **Physical immediate successor** | **`MED=None` L1511** (jsonl **1792**) — **Universal Potency Selection Logic** — **not GE** |
| **Canonical audit predecessor** | **F2** — **not physically adjacent** in normalized 019c walk |
| **Canonical audit successor** | **L1** — **L1 (`MED=L1` ~L1336) physically precedes GE (~L1467)** in corpus order |
| **Duplicate owner-primary GE block** | **None** located |
| **Registry v2 blob (@ base)** | `packages/medicine-registry/src/medicines.v2.json` |
| **Manifest (@ base)** | `packages/medicine-registry/src/registry.v2.manifest.json` |

---

## 3. Audit scope and non-authorization banner

This record is a **documentation-only** source and governance audit for **GE / Green Electricity**. It:

- Inventories and compares sources; records **technical governance classifications (TGC)** **as documentation**.
- Does **not** clinically validate GE, authorize potency/dosage, **electricity use**, route/application, co-administration, evidence activation, orchestration, or Rule 6 medicine relationships.
- Does **not** treat registry/legacy/MM3 BOOK/UCKB strings or **developer/API/mock GE enums** as owner-verified clinical truth.
- Does **not** invent or claim a normalized **`MED=GE`** header.
- Preserves disease/indication **source-tier inventory** with **zero** mapping or selection authority.
- **Documentation completion creates no clinical authority and no electricity-use authority.**
- Does **not** substitute for oncology, infectious-disease, surgical, emergency, or standard medical care.

**Posture flags (final):**

| Flag | Value |
|------|--------|
| `clinicallyValidated` | `false` |
| `rule5SafetyCoverageComplete` | `false` |
| `ownerPrimaryVerified` | `false` |
| `ownerSourceStatus` | **`LOCATED_REVIEWED`** (index) · artifact **`PROVISIONAL_OWNER_PRIMARY`** — **`MED=None` L1467**; **no `MED=GE` header** |
| `provenanceStatus` | **`INCOMPLETE_NOT_VERIFIED`** |
| `routeAuthority` | `APPLICATION_ROUTE_AUTHORITY_NONE` |
| `potencyAuthorized` | `false` |
| `dosageAuthorized` | `false` |
| `electricityAuthorized` | `false` |
| `evidenceActivated` | `false` |
| `rule6MedicineRelationshipAuthority` | `NONE` |
| `runtimeAuthorized` | `false` |

---

## 4. GE canonical identity (typed tracks)

| Field | Registry v2 | Owner-primary (occurrence **A** @ **`MED=None` L1467**) | Notes |
|-------|-------------|-----------------------------------------------------------|--------|
| **Code** | GE | GE (semantic in body — **not** `MED=GE` header) | 38-set identity **VERIFIED** |
| **Display name** | Green Electricity | GREEN ELECTRICITY (GE) | Electricity master framing |
| **Group** | **Electricity** | Green Electricity / anti-septic & anti-malignant electricity | **Not** oral materia group |
| **Owner medicine number** | (registry narrative) | **38** in owner block | Owner-only metadata |
| **Polarity field** | **NEGATIVE** | **Neutral** philosophy in §1 owner text | **Inventory only** — conflict **OPEN** (TGC-GE-009) |

---

## 5. Owner corpus: no `MED=GE` — occurrence **A** at `MED=None`

Reference: legacy normalized `docs/phase-s5-mm1e/_doctor_medicine_corpus.txt` (read-only pointer; not modified).

**Negative search:** pattern **`^MED=GE`** → **zero matches** in normalized 019c corpus.

| ID | Header line | Transcript | jsonl line | len | Markers | Classification |
|----|-------------|------------|------------|-----|---------|----------------|
| **A** | **`MED=None` L1467** | `019c5012-fbb1-4582-a4af-af8484d1bc5f\…jsonl` | **1780** | **2916** | potency, bodyloc, electricity | **`PROVISIONAL_OWNER_PRIMARY`** — owner-session **Green Electricity** master only |

Developer/API/mock **`GE`** routing strings elsewhere in corpus and alternate sessions are **rejected** as owner materia authority — **not** co-primary (**CF-GE-011**).

---

## 6. Occurrence A — provisional owner-primary boundary map

| Corpus region | Lines | Role | Clinical / electricity authority |
|---------------|-------|------|----------------------------------|
| **Corpus metadata header** | **L1467** | **`MED=None`** + jsonl **1780** / **2916** | **Normaliser gap** — not `MED=GE` |
| **Inner wrapper open** | **L1470** | `<user_query>` | Boundary only |
| **Cursor/Database save** | **L1471–L1472** | Developer persistence instruction | **Excluded** — non-clinical |
| **§1–3 + §4 potency** | **L1475–L1502** | Electricity philosophy, affinity, disease clusters, potency §4 | **Provisional inventory only** |
| **§5 keywords / 116k tags** | **L1503–L1504** | Keyword workflow label | **Excluded** — non-operational |
| **Expert tip** | **L1505–L1506** | Cancer/Gangrene/Fistula/Necrosis priority + **C5+Ven1+GE** | **Provisional inventory only** — **no post-tip agent tail** |
| **Wrapper close** | **L1507** | `</user_query>` | Boundary only |
| **Physical predecessor** | **YE** — close **L1464** | Prior electricity master | Adjacency only |
| **Physical immediate successor** | **`MED=None` L1511** (jsonl **1792**) | Universal potency logic block | **Not GE** |
| **Canonical predecessor / successor** | **F2** / **L1** | Index audit order | **Not adjacent** — **L1 before GE** in file walk |

---

## 7. Sources and provenance

| Source ID | Classification | Reference | Status |
|-----------|----------------|-----------|--------|
| **SRC-GE-OWNER-A** | **`PROVISIONAL_OWNER_PRIMARY`** | **`MED=None` L1467** · bounded **L1475–1502** + expert tip **L1505–1506** · wrapper **L1470–1507** · jsonl **1780** | Located · **no `MED=GE` header** · byte proof **pending** |
| **SRC-GE-MM1E-IDX** | Normalized index | jsonl **1780** / semantic GE | Aligned mirror · **`MED=None` indexing** |
| **SRC-GE-MM2** | Parsed owner copy | `S5MM2_MASTER_MATERIA_MEDICA.json` · `PRIMARY_DOCTOR_BLOCK_FOUND` | **Secondary** · truncated title **`…38: G`** |
| **SRC-GE-MM2C** | Clinical classification | `S5MM2C_CLINICAL_CLASSIFICATION.json` | **`INTERNAL_ONLY` / staging** · ICD **`review_required`** |
| **SRC-GE-REG-V2** | Registry v2 | `medicines.v2.json` **GE** | **`DERIVED_UNVERIFIED`** · **`Electricity`** group |
| **SRC-GE-LEGACY-DUMP** | Legacy stub | `_electrohomeo_medicines_dump.json` (expected path) | **Not located** — gap **OPEN** |
| **SRC-GE-MM3** | MM3/BOOK | `S5_MM3_MASTER_MATERIA_MEDICA.json` | **`UNVERIFIED_BOOK_DERIVED_TEXT`** · quarantine |
| **SRC-GE-UCKB** | Parallel | `UCKB_DATASET_v1.json` | **`NOT_ACTIVATED`** · external route + combination staging |
| **SRC-GE-DEV-API** | Dev/API/mock | Non-owner **GE** enums/lists | **Rejected** |

**No derived tier may be merged into owner-primary clinical truth.**

---

## 8. Technical governance classification (`TECHNICAL_GOVERNANCE_CLASSIFICATION`)

**`TECHNICAL_GOVERNANCE_CLASSIFICATION_COUNT: 10`**

| ID | Token |
|----|--------|
| **TGC-GE-001** | `CANONICAL_GE_38_SET_OWNER_BLOCK_MED_NONE_L1467_JSONL_1780_NO_MED_EQ_GE_HEADER_F2_CANONICAL_PREDECESSOR_L1_PHYSICAL_PREDECESSOR_YE_L1_CANONICAL_SUCCESSOR_NOT_ADJACENT` |
| **TGC-GE-002** | `RULE4_GE_REFERENCE_ZERO_AUTHORITY_IN_OWNER_ELECTRICITY_BLOCK` |
| **TGC-GE-003** | `SEPARATE_TRACKS_NO_GE_POTENCY_DILUTION_AUTHORITY_MM3_UCKB_BOOK_D1000_TABLET_EXTERNAL_QUARANTINE` |
| **TGC-GE-004** | `RE_BE_WE_YE_GE_ELECTRICITY_COADMINISTRATION_ZERO_AUTHORITY_UCKB_MM3_STAGING_QUARANTINED` |
| **TGC-GE-005** | `DISEASE_INDICATION_MAPPING_ZERO_AUTHORITY` |
| **TGC-GE-006** | `APPLICATION_ROUTE_AUTHORITY_NONE_OWNER_SILENT_MM2C_UCKB_EXTERNAL_STAGING_REJECTED` |
| **TGC-GE-007** | `RULE6_C5_VEN1_GE_SUPER_COMBO_AND_116K_PRIORITY_TIP_INVENTORY_ONLY` |
| **TGC-GE-008** | `MM3_BOOK_OCR_QUARANTINE_NO_OWNER_MERGE` |
| **TGC-GE-009** | `POLARITY_CATEGORY_NEUTRAL_OWNER_ELECTRICITY_VS_REGISTRY_MM2_NEGATIVE_VS_BOOK_NEGATIVE_CONFLICT` |
| **TGC-GE-010** | `KEYWORD_DEFAULT_CANCER_GANGRENE_FISTULA_NECROSIS_ANTI_CANCER_GE_PRIORITY_LANGUAGE_REJECTED` |

**Index `RECORDED_0`:** documentation audit **complete**; **zero** essential owner clinical decisions; **TGC-GE-001–010** recorded **separately** (count **10**).

---

## 9. Essential owner clinical decisions

**`ESSENTIAL_OWNER_CLINICAL_DECISIONS: NONE — BLOCKED BY MISSING VERIFIED PRIMARY AND RULE 5 SAFETY EVIDENCE`**

- **Essential owner clinical decision count:** **0**
- **No EOD-GE table**
- Registry/MM2/MM3/UCKB/dev derivations and **`MED=None` normalizer gaps** are **TGC/CF/ME** — **not** owner clinical approval questions.

---

## 10. Provisional owner-source inventory (mapping inactive)

Preserved **only** as historical/source-tier inventory from bounded occurrence **A**:

- Necrosis/malignancy cleanser language; **Neutral** electricity philosophy (inventory only)
- **Cancer**, **gangrene**, **fistula**, bed sores, diabetic foot, malignant/deep pain wording
- **PCOD/fibroid/gonorrhea** necrosis language
- **Potency §4:** **D1–D3**, **D5**, **D10–D30**, **D60–D1000** bands — inventory only
- Keywords: Anti-Cancer-Electricity, Gangrene-Relief, Fistula-Support, etc. (**116k region excluded**)
- Expert tip: **116k priority** for Cancer/Gangrene/Fistula/Necrosis; **C5 + Ven1 + GE** “super-combination” — inventory only (**TGC-GE-007**)

---

## 11. High-stakes source claims (inventory only)

Cancer, gangrene, fistula, anti-cancer electricity, necrosis cleansing, malignant pain relief, and default GE priority language are **provisional historical/source inventory** only.

**Explicitly not asserted:**

- No **treatment** or **cure** authority
- No **anti-cancer efficacy** authority
- No **gangrene/fistula management** authority
- No **emergency** or **standard-care substitution**
- No **safety** authority
- No **potency/dosage authorization** (including **D1000** band vs quarantined BOOK/tablet text)
- No **route/application authority**
- No **electricity-use** or **co-administration authority**
- No **disease mapping** or **116k activation**
- No **keyword/default selection** authority
- No **selector** or **runtime** activation
- No **Rule 6 relationship** authority

---

## 12. Disease / Indication Mapping Status

| Flag | Value |
|------|--------|
| `diseaseClaimsClinicallyValidated` | `false` |
| `diseaseMedicineMappingAuthorized` | `false` |
| `diseaseMedicineMappingImplemented` | `false` |
| `affectsClinicalSelection` | `false` |

**Explicitly inactive:** no 116k mapping; no cancer/gangrene/fistula/necrosis keyword priority; no default GE selection; no selector activation; no route/electricity/runtime activation (TGC-GE-005, TGC-GE-010).

---

## 13. Registry / legacy derived inventory (`DERIVED_UNVERIFIED`)

English anti-septic/anti-malignant/necrosis narrative; cancer/gangrene/fistula clusters; **C5+Ven1+GE** hints; search tags — **inventory only**; **no** clinical, electricity-use, or selector authority.

**Legacy dump:** **not located** at audit time — **ME/CF gap** (not silently closed).

---

## 14. MM3 / BOOK quarantine

**TGC-GE-008** — **`UNVERIFIED_BOOK_DERIVED_TEXT`**; **`no_merge_with_owner_primary`**; OCR/internal–external caution fragments — **zero** Rule 5, route, potency, disease-mapping, electricity, or runtime credit.

---

## 15. UCKB staging (`NOT_ACTIVATED`)

External lotion/compress/ointment routes; **C5+GE** / **C1+GE** pairings — **quarantined**; **TGC-GE-004**. **No activation.**

---

## 16. Authority boundaries (consolidated)

| Domain | Classification |
|--------|----------------|
| **Rule 4** | **TGC-GE-002** — zero Rule 4 medicine reference in owner GE electricity block **A** |
| **Potency / dilution** | **TGC-GE-003** — owner §4 inventory only; MM3/UCKB/BOOK bands/tablets/external **rejected** |
| **RE / BE / WE / YE / GE co-administration** | **TGC-GE-004** — UCKB/MM3 staging **quarantined** |
| **Route / application** | **TGC-GE-006** — **`APPLICATION_ROUTE_AUTHORITY_NONE`**; MM2C/UCKB external claims **rejected** |
| **Rule 6 / C5+Ven1+GE / 116k priority** | **TGC-GE-007** — **inventory only**; **no runtime combination edge** |
| **Polarity / Electricity category** | **TGC-GE-009** — inventory only |
| **Keyword / cancer / gangrene / anti-cancer GE priority** | **TGC-GE-010** — rejected |

---

## 17. Rule 5 safety matrix (summary)

| Domain | Status |
|--------|--------|
| Contraindications | **SOURCE_NOT_FOUND** (owner block **A**; BOOK text **no credit**) |
| Allergy / hypersensitivity | **SOURCE_NOT_FOUND** |
| Adverse effects | **SOURCE_NOT_FOUND** |
| Medicine interactions | **SOURCE_NOT_FOUND** |
| Condition interactions | **SOURCE_NOT_FOUND** |
| Pregnancy / lactation / special populations | **SOURCE_NOT_FOUND** |
| Pediatric / geriatric considerations | **SOURCE_NOT_FOUND** |
| Route incompatibility | **SOURCE_NOT_FOUND** (owner route silent) |
| Application-site safety | **SOURCE_NOT_FOUND** |
| Overdose / exposure | **SOURCE_NOT_FOUND** |
| Electricity exposure / co-administration safety | **SOURCE_NOT_FOUND** |
| Duration / cumulative risk | **SOURCE_NOT_FOUND** |
| Monitoring | **SOURCE_NOT_FOUND** |
| Pause/stop criteria | **SOURCE_NOT_FOUND** |
| Emergency / red-flag criteria | **SOURCE_NOT_FOUND** |
| Follow-up timing | **SOURCE_NOT_FOUND** |
| Cancer/gangrene/necrosis escalation | **SOURCE_NOT_FOUND** (inventory text **not** safety evidence) |
| Standard-care substitution limits | **SOURCE_NOT_FOUND** |

**Rule 5 safety evidence:** source **not found** across required domains. BOOK/MM3/UCKB: **zero Rule 5 credit**. **`rule5SafetyCoverageComplete: false`**.

---

## 18. Conflict register

| ID | Disposition |
|----|-------------|
| **CF-GE-001** | **OPEN** — no **`MED=GE`** vs located **`MED=None` L1467** / jsonl **1780** |
| **CF-GE-002** | **OPEN** — **2916** vs MM3 **2912** |
| **CF-GE-003** | **OPEN** — canonical **F2→GE→L1** vs physical order (**L1 before GE**; F2 distant) |
| **CF-GE-004** | **OPEN** — medicine code **GE** vs **Green Electricity** registry category |
| **CF-GE-005** | **OPEN** — owner **Neutral** vs registry/MM2 **NEGATIVE** vs BOOK polarity |
| **CF-GE-006** | **OPEN** — compress/application-site discrepancies (MM2C/UCKB vs MM1E CSV mirrors) |
| **CF-GE-007** | **OPEN** — BOOK internal/external cautions vs absent owner Rule 5 |
| **CF-GE-008** | **OPEN** — MM2 title truncation **`औषधि संख्या 38: G`** |
| **CF-GE-009** | **OPEN** — UCKB **C5+GE** / **C1+GE** relationship pairs vs unverified Rule 6 |
| **CF-GE-010** | **OPEN** — missing legacy dump location |
| **CF-GE-011** | **OPEN** — developer/API **GE** routing vs single owner electricity master |
| **CF-GE-012** | **CLOSED** — keyword/default/cancer/gangrene **GE priority** activation **REJECTED** (TGC-GE-010); wording remains inventory |
| **CF-GE-013** | **CLOSED** — BOOK/MM3/UCKB **external-route/electricity** activation **REJECTED**; **`routeAuthority` remains none** |

**No silent reconciliation.** A **CLOSED** rejection does **not** imply clinical validation.

**Mandatory CF summary:** CF: 001–011 OPEN (11 entries) · 012–013 CLOSED (2 entries; governance rejections only)

---

## 19. Missing-evidence register

| ID | Topic | Status |
|----|--------|--------|
| **ME-GE-001** | Transcript bytes and **2916** declared length | **OPEN** |
| **ME-GE-002** | License/publication/redistribution provenance | **OPEN** |
| **ME-GE-003** | Owner-primary Rule 5 safety text | **OPEN** |
| **ME-GE-004** | Verified route/application evidence | **OPEN** |
| **ME-GE-005** | Potency/dosage protocol and **D1000** ceiling | **OPEN** |
| **ME-GE-006** | MM3/BOOK/UCKB OCR and bibliographic integrity | **OPEN** |
| **ME-GE-007** | **C5+Ven1+GE** and 116k priority relationship evidence | **OPEN** |
| **ME-GE-008** | Cancer/gangrene/necrosis escalation and standard-care boundaries | **OPEN** |
| **ME-GE-009** | **`MED=GE` normalizer** vs semantic GE block reconciliation | **OPEN** |
| **ME-GE-010** | Legacy-dump location and source-tier reconciliation | **OPEN** |

Evidence gaps only — **not** EODs.

**Mandatory ME summary:** ME: 001–010 OPEN (10 entries)

---

## 20. Audit footer (mandatory)

| Item | Value |
|------|--------|
| Medicine | GE (18/38) |
| Canonical main SHA | `7ff19249044c885773c489558c527a51a1d1fe4f` |
| Verdict | `GE_DOCUMENTATION_AUDIT_COMPLETE_CLINICAL_AND_SAFETY_BLOCKED` |
| Owner-primary | **`PROVISIONAL_OWNER_PRIMARY`** (occurrence **A** @ **`MED=None` L1467**) · **`LOCATED_REVIEWED`** (provisional) · **no `MED=GE` header** |
| `ownerPrimaryVerified` | **`false`** |
| Provenance | **`INCOMPLETE_NOT_VERIFIED`** |
| Essential owner clinical decisions | **NONE — BLOCKED…** (**count 0** · **`RECORDED_0`**) |
| TGC | **TGC-GE-001–010** · count **10** |
| Clinical / safety / evidence | **NO / NO / NONE** |
| Mapping flags | **all false** |
| Route / potency / dosage / electricity / Rule 6 | **NONE / false / false / false / NONE** |
| CF | **001–011 OPEN (11 entries) · 012–013 CLOSED (2 entries; governance rejections only)** |
| ME | **001–010 OPEN (10 entries)** |
| Next canonical medicine (sequence) | **L1** — **not** started or targeted |
| Registry / runtime changed | **NO** |
| PHI / secrets / database | **NONE** |

**Authority tag:** DOCUMENTATION_ONLY_MEDICINE_AUDIT · **GE blocked · MED=None electricity master · no electricity-use authority · zero essential owner clinical decisions**
